赛默飞世尔科技：4Q25 results: Capitalizing on the growing pharmaceutical demand-20260202

2 Feb 2026 CMB International Global Markets | Equity Research | Company Update Thermo Fisher (TMO US) Thermo Fisher (TMO US) - 4Q25 results: Capitalizing on the growing pharmaceutical demand Thermo Fisher (TMO) delivered a strong 4Q25 performance, with revenue up by 7.2% YoY (the fastest quarterly growth within 2025) and adj. EPS up by 7.7%, beating Bloomberg consensus by 2.2%/ 1.9%, respectively. The upbeat growth in the quarter was firmly supported by the solid performance of bioproduction, research and s ...